等待开盘 04-03 09:30:00 美东时间
-0.540
-1.78%
今日重点评级关注:Canaccord Genuity:维持Generac控股"买入"评级,目标价从275美元升至300美元;Oppenheimer:维持Biogen"跑赢大市"评级,目标价从250美元升至275美元
04-02 16:17
Wells Fargo analyst Joseph O'Dea maintains Centuri Holdings (NYSE:CTRI) with a Overweight and lowers the price target from $34 to $32.
04-02 00:15
今日重点评级关注:HC Wainwright & Co.:维持OCUGEN"买入"评级,目标价从7美元升至10美元;HC Wainwright & Co.:维持Maze Therapeutics"买入"评级,目标价从60美元升至110美元
03-26 11:41
Cantor Fitzgerald analyst Manish A. Somaiya maintains Centuri Holdings (NYSE:CTRI) with a Overweight and raises the price target from $35.25 to $37.4.
03-25 21:38
今日重点评级关注:巴克莱:维持C4 Therapeutics"超配"评级,目标价从5美元升至7美元;富国银行:维持Agilon Health"超配"评级,目标价从1美元升至1.5美元
03-02 14:08
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从47美元升至49美元;Citizens:维持Ironwood医药"跑赢大市"评级,目标价从8美元升至10美元
02-27 11:07
Wells Fargo analyst Joseph O'Dea maintains Centuri Holdings (NYSE:CTRI) with a Overweight and raises the price target from $30 to $34.
02-27 00:04
华盛资讯2月26日讯,Centuri Holdings, Inc.公布2025财年年度业绩,公司年度营收29.83亿美元,同比增长13.1%,归母净利润0.22亿美元,扭亏为盈。
02-26 22:17
华盛资讯2月25日讯,Centuri Holdings, Inc.公布2025财年Q4业绩,公司Q4营收8.59亿美元,同比增长19.7%,归母净利润0.30亿美元,同比增长194.1%。
02-25 21:18
Full Year 2026 Financial GuidanceBase Revenue and Base Gross Profit do not include contributions from storm restoration services, which are unpredictable. While storm restoration services remain a key capability of the
02-25 21:07